These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34402205)

  • 21. Efficacy and possible mechanisms of Botulinum Toxin type A on hypertrophic scarring.
    Hao R; Li Z; Chen X; Ye W
    J Cosmet Dermatol; 2018 Jun; 17(3):340-346. PubMed ID: 29569821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Austin E; Koo E; Jagdeo J
    Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on the Maxillofacial Area and Neck: A Meta-Analysis of Randomized Controlled Trials.
    Zhang DZ; Liu XY; Xiao WL; Xu YX
    PLoS One; 2016; 11(3):e0151627. PubMed ID: 26985661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term effect of botulinum toxin type A injection on hypertrophic acne scar].
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):432-7. PubMed ID: 30067322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Research of Botulinum Toxin Type A in Prevention and Treatment on Pathological Scars.
    Wang YX; Wang Y; Zhang Q; Zhang RD
    Dermatol Surg; 2023 May; 49(5S):S34-S40. PubMed ID: 37115998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of botulinum toxin type A for treating hypertrophic scars: A split-scar, double-blind randomized controlled trial.
    Elshahed AR; Elmanzalawy KS; Shehata H; ElSaie ML
    J Cosmet Dermatol; 2020 Sep; 19(9):2252-2258. PubMed ID: 32668499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
    Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
    Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of Nd:YAG laser alone compared with combined Nd:YAG laser with intralesional steroid or botulinum toxin A in the treatment of hypertrophic scars.
    Rahman SHA; Mohamed MS; Hamed AM
    Lasers Med Sci; 2021 Jun; 36(4):837-842. PubMed ID: 32812129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids.
    Sabry HH; Ibrahim EA; Hamed AM
    Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
    Zhuang Z; Li Y; Wei X
    Burns; 2021 Aug; 47(5):987-998. PubMed ID: 33814214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Sun LC; Chen R; Fu C; Chen Y; Wu Q; Chen R; Lin X; Luo S
    Biomed Res Int; 2019; 2019():8329306. PubMed ID: 31080830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.
    Xie S; Wang K; Xu T; Guo XS; Shan XF; Cai ZG
    Cancer Med; 2015 Nov; 4(11):1639-50. PubMed ID: 26310612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy of Drug Injection in the Treatment of Pathological Scar: A Network Meta-analysis.
    Sun P; Lu X; Zhang H; Hu Z
    Aesthetic Plast Surg; 2021 Apr; 45(2):791-805. PubMed ID: 31853608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars.
    Elhefnawy AM
    Indian J Dermatol Venereol Leprol; 2016; 82(3):279-83. PubMed ID: 27088929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on the Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis-Is the Observed Effect due to Botulinum Neurotoxicity?
    Atiyeh BS; Chahine F
    Aesthetic Plast Surg; 2022 Apr; 46(Suppl 1):182-183. PubMed ID: 33913015
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report.
    Xiao Z; Zhang F; Lin W; Zhang M; Liu Y
    Aesthetic Plast Surg; 2010 Aug; 34(4):424-7. PubMed ID: 19802513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial.
    Huang RL; Ho CK; Tremp M; Xie Y; Li Q; Zan T
    Plast Reconstr Surg; 2019 Oct; 144(4):835-844. PubMed ID: 31568286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Botulinum Toxin in the Treatment of Facial and Cervical Hypertrophic Scar: A Meta-Analysis.
    Yin D; Xi M; Jiang L; Du M; Qi J
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.